Preliminary reports indicate conolidine may perhaps inhibit certain ion channels, minimizing neuronal excitability and limiting agony signals. This mechanism is particularly related in neuropathic pain, the place irregular signaling brings about persistent soreness. In addition, conolidine seems to affect G protein-coupled receptor (GPCR) pathways